These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2572652)

  • 1. Influence of antihistamine pretreatment on vancomycin-induced red-man syndrome.
    Sahai J; Healy DP; Garris R; Berry A; Polk RE
    J Infect Dis; 1989 Nov; 160(5):876-81. PubMed ID: 2572652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome".
    Sahai J; Healy DP; Shelton MJ; Miller JS; Ruberg SJ; Polk R
    Antimicrob Agents Chemother; 1990 May; 34(5):765-9. PubMed ID: 1694421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions.
    Healy DP; Sahai JV; Fuller SH; Polk RE
    Antimicrob Agents Chemother; 1990 Apr; 34(4):550-4. PubMed ID: 1693055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihistamine prophylaxis permits rapid vancomycin infusion.
    Renz CL; Thurn JD; Finn HA; Lynch JP; Moss J
    Crit Care Med; 1999 Sep; 27(9):1732-7. PubMed ID: 10507591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial.
    Brockow K; Kiehn M; Riethmüller C; Vieluf D; Berger J; Ring J
    J Allergy Clin Immunol; 1997 Oct; 100(4):458-63. PubMed ID: 9338537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine release during rapid vancomycin administration.
    Renz C; Lynch J; Thurn J; Moss J
    Inflamm Res; 1998; 47 Suppl 1():S69-70. PubMed ID: 9561421
    [No Abstract]   [Full Text] [Related]  

  • 7. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release.
    Polk RE; Healy DP; Schwartz LB; Rock DT; Garson ML; Roller K
    J Infect Dis; 1988 Mar; 157(3):502-7. PubMed ID: 2449506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red man syndrome: incidence, etiology, and prophylaxis.
    Wallace MR; Mascola JR; Oldfield EC
    J Infect Dis; 1991 Dec; 164(6):1180-5. PubMed ID: 1955716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacodynamics and clinical adverse effects of mivacurium. The effect of oral premedication with H1/H2 antagonists].
    Mayer M; Doenicke A; Nebauer AE; Rosenberger C; Lorenz W; Peter K
    Anaesthesist; 1993 Sep; 42(9):592-6. PubMed ID: 8105716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone hypersensitivity syndrome during delayed pressure urticaria treatment.
    do Valle SO; França AT; Pires GV; Guimarães P; Dias GA; Levy SA
    Ann Allergy Asthma Immunol; 2010 Feb; 104(2):181-2. PubMed ID: 20306824
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.
    Rybak MJ; Bailey EM; Warbasse LH
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1204-7. PubMed ID: 1384423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antihistamines reduce the side effects from rapid vancomycin infusion.
    Renz CL; Thurn JD; Finn HA; Lynch JP; Moss J
    Anesth Analg; 1998 Sep; 87(3):681-5. PubMed ID: 9728853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions.
    Renz CL; Laroche D; Thurn JD; Finn HA; Lynch JP; Thisted R; Moss J
    Anesthesiology; 1998 Sep; 89(3):620-5. PubMed ID: 9743397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
    Wan KS
    J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of H1 and H2 antagonists for chemoprophylaxis: a double-blind, placebo-controlled study in healthy volunteers.
    Doenicke A; Moss J; Toledano A; Hoernecke R; Lorenz W; Ostwald P
    J Clin Pharmacol; 1997 Feb; 37(2):140-6. PubMed ID: 9055140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin test wheal size and erythema not reduced by topical antihistamine.
    Gibbs CJ; Coutts II; Jackson SM; White RJ
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1427-8. PubMed ID: 6139139
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of histamine-induced pruritus by hydroxyzine and various neuroleptics.
    Arnold AJ; Simpson JG; Jones HE; Ahmed AR
    J Am Acad Dermatol; 1979 Dec; 1(6):509-12. PubMed ID: 43338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of red man syndrome in patients receiving vancomycin.
    O'Sullivan TL; Ruffing MJ; Lamp KC; Warbasse LH; Rybak MJ
    J Infect Dis; 1993 Sep; 168(3):773-6. PubMed ID: 8354921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of preventing effect of systemically and topically administered histamine H(1) or H(4) receptor antagonists in a dog model of acute atopic dermatitis.
    Bäumer W; Stahl J; Sander K; Petersen LJ; Paps J; Stark H; Kietzmann M; Olivry T
    Exp Dermatol; 2011 Jul; 20(7):577-81. PubMed ID: 21521369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists.
    Lin RY; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE
    Ann Emerg Med; 2000 Nov; 36(5):462-8. PubMed ID: 11054200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.